Explore
Trendline
Sagimet Biosciences Reports $14 Million Q2 Loss, Plans Phase 3 Acne Trial
Sagimet Biosciences Reports $14 Million Q2 Loss, Plans Phase 3 Acne Trial
Read More
Trendline
Johnson Johnson and Abbott Laboratories: Evaluating Growth Prospects Post-Earnings
Johnson Johnson and Abbott Laboratories: Evaluating Growth Prospects Post-Earnings
Read More
Trendline
Plug Power Exceeds Revenue Expectations and Raises 2026 Guidance
Plug Power Exceeds Revenue Expectations and Raises 2026 Guidance
Read More
Trendline
Sezzle Reports Record Revenue Growth but Faces Stock Value Decline
Sezzle Reports Record Revenue Growth but Faces Stock Value Decline
Read More
Trendline
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure
Read More
Trendline
ArcBest Reports Q2 2026 Financial Results Amidst Market Challenges
ArcBest Reports Q2 2026 Financial Results Amidst Market Challenges
Read More
Trendline
Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development
Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development
Read More
Trendline
Omeros Corporation to Release Q2 Financial Results Amid Strategic Developments
Omeros Corporation to Release Q2 Financial Results Amid Strategic Developments
Read More
Trendline
Rigetti Computing's Q2 Results Show Revenue Growth Amid Increased Losses
Rigetti Computing's Q2 Results Show Revenue Growth Amid Increased Losses
Read More
Trendline
AAON Prepares for Q2 2026 Earnings Amid Insider Trading and Hedge Fund Activity
AAON Prepares for Q2 2026 Earnings Amid Insider Trading and Hedge Fund Activity
Read More
Trendline
Palantir Reports Record Q2 Earnings, Sparking Investor Debate Over Valuation
Palantir Reports Record Q2 Earnings, Sparking Investor Debate Over Valuation
Read More
Trendline
Dell Technologies Reports Strong Earnings with Significant Revenue Growth
Dell Technologies Reports Strong Earnings with Significant Revenue Growth
Read More